Nantahala Capital Management LLC Takes Position in Keros Therapeutics, Inc. $KROS
MarketBeat
Nantahala Capital Management LLC bought a new position in Keros Therapeutics, Inc. (NASDAQ:KROS - Free Report) during the 2nd quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund bought 1,410,419 shares of the company's stock,
NASDAQ:KROS